Nextage Therapeutics Ltd (NXTG.TA)
ILA 104.5
(0.97%)
ILA 104.5
(0.97%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 876 Thousand ILS | 0.0% |
| 2022 | - ILS | -100.0% |
| 2021 | 91 Thousand ILS | -52.36% |
| 2020 | 191 Thousand ILS | -35.69% |
| 2019 | 297 Thousand ILS | -22.45% |
| 2018 | 383 Thousand ILS | -5.43% |
| 2017 | 405 Thousand ILS | 1346.43% |
| 2016 | 28 Thousand ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 876 Thousand ILS | 0.0% |
| 2023 Q2 | 163 Thousand ILA | 0.0% |
| 2023 Q4 | 713 Thousand ILA | 337.42% |
| 2022 Q4 | - ILA | 0.0% |
| 2022 FY | - ILS | -100.0% |
| 2022 Q2 | - ILA | 0.0% |
| 2021 Q2 | 140 Thousand ILA | -12.5% |
| 2021 FY | 91 Thousand ILS | -52.36% |
| 2020 Q2 | 165 Thousand ILA | -3.51% |
| 2020 Q4 | 160 Thousand ILA | -3.03% |
| 2020 FY | 191 Thousand ILS | -35.69% |
| 2019 FY | 297 Thousand ILS | -22.45% |
| 2019 Q4 | 171 Thousand ILA | 35.71% |
| 2019 Q2 | 126 Thousand ILA | -0.79% |
| 2018 Q4 | 127 Thousand ILA | 0.0% |
| 2018 FY | 383 Thousand ILS | -5.43% |
| 2017 FY | 405 Thousand ILS | 1346.43% |
| 2016 FY | 28 Thousand ILS | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cannabotech LTD | 1.21 Million ILA | 28.138% |